CMS could pay certain eligible hospitals approximately $9 billion in total as part of its plan to remedy unlawful cuts to the 340B drug discount program between 2018 and 2022, according to a proposed rule. However, the remedy would come at the cost of cuts to non-drug items and services...Read More »
Hospitals have made significant efforts to comply with price transparency regulations due to increased civil monetary penalties from CMS, according to a recent JAMA Network Open study.Read More »
